Saini S, Gadet J, Freeman G, Chiocca E, Mineo M
J Neurooncol. 2025; .
PMID: 40035950
DOI: 10.1007/s11060-025-04978-2.
Yuan H, Zhou L, Hu W, Yang M
Sci Rep. 2025; 15(1):2997.
PMID: 39848992
PMC: 11757752.
DOI: 10.1038/s41598-025-86287-2.
Wang Z, Wang P, Yang C
Curr Environ Health Rep. 2024; 12(1):3.
PMID: 39715843
PMC: 11755759.
DOI: 10.1007/s40572-024-00468-1.
Han L, Yang H, Jiang X, Zhou Z, Ge C, Yu K
Front Immunol. 2024; 15:1512203.
PMID: 39687628
PMC: 11647029.
DOI: 10.3389/fimmu.2024.1512203.
Deng X, Zhang Q, Jin F, Lu F, Duan G, Han L
Cancer Cell Int. 2024; 24(1):397.
PMID: 39639311
PMC: 11619249.
DOI: 10.1186/s12935-024-03594-w.
FunlncModel: integrating multi-omic features from upstream and downstream regulatory networks into a machine learning framework to identify functional lncRNAs.
Li Y, Qian F, Zhang G, Li X, Zhou L, Yu Z
Brief Bioinform. 2024; 26(1).
PMID: 39602828
PMC: 11601888.
DOI: 10.1093/bib/bbae623.
Identification of anoikis-related long non-coding RNA signature as a novel prognostic model in lung adenocarcinoma.
Fang X, Wei M, Liu X, Lu L, Liu G
Transl Cancer Res. 2024; 13(10):5458-5472.
PMID: 39525036
PMC: 11543027.
DOI: 10.21037/tcr-24-264.
LncRNA DDX11-AS1 promotes breast cancer progression by targeting the miR-30c-5p/MTDH axis.
Li Y, Zhou M, Yang L, Liu S, Yang L, Xu B
Sci Rep. 2024; 14(1):26745.
PMID: 39501057
PMC: 11538490.
DOI: 10.1038/s41598-024-78413-3.
Multi-view learning framework for predicting unknown types of cancer markers via directed graph neural networks fitting regulatory networks.
Wang X, Huang L, Wang Y, Guan R, You Z, Sheng N
Brief Bioinform. 2024; 25(6).
PMID: 39470307
PMC: 11514060.
DOI: 10.1093/bib/bbae546.
Identification and experimental validation of a sialylation-related long noncoding RNA signature for prognosis of bladder cancer.
Qiao Y, Tian X, Li S, Niu H
BMC Urol. 2024; 24(1):222.
PMID: 39390546
PMC: 11465731.
DOI: 10.1186/s12894-024-01613-6.
Long non-coding RNA PVT1 regulates TGF-β and promotes the proliferation, migration and invasion of hypopharyngeal carcinoma FaDu cells.
Zhao Y, Zhao L, Li M, Meng Z, Wang S, Li J
World J Surg Oncol. 2024; 22(1):254.
PMID: 39300515
PMC: 11414033.
DOI: 10.1186/s12957-024-03536-w.
DNAJC3-AS1 Is Associated with Proliferation, Metastasis, and Poor Prognosis of Breast Cancer.
Zhang Y, Li J, Luo B, Guo X, Liu J, Yang S
Dis Markers. 2024; 2021:3443474.
PMID: 39290802
PMC: 11407888.
DOI: 10.1155/2021/3443474.
The Association between the NLRP3 Inflammasome and Specific Long-Non Coding RNAs (lncRNAs) in Cancer; New Perspective and Summary of Recent Studies.
Alsaab H, Almalki Y
Cell Biochem Biophys. 2024; 83(1):147-158.
PMID: 39285156
DOI: 10.1007/s12013-024-01494-4.
ARAP1-AS1: a novel long non-coding RNA with a vital regulatory role in human cancer development.
Wang J, Luo H, Yang L, Yuan H
Cancer Cell Int. 2024; 24(1):270.
PMID: 39090630
PMC: 11295494.
DOI: 10.1186/s12935-024-03435-w.
A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma.
Huang K, Gui C, Xu Y, Li X, Zhao H, Cao J
Nat Commun. 2024; 15(1):6215.
PMID: 39043664
PMC: 11266571.
DOI: 10.1038/s41467-024-50369-y.
LncRNAs are involved in regulating ageing and age-related disease through the adenosine monophosphate-activated protein kinase signalling pathway.
Li J, Xiao F, Wang S, Fan X, He Z, Yan T
Genes Dis. 2024; 11(5):101042.
PMID: 38966041
PMC: 11222807.
DOI: 10.1016/j.gendis.2023.06.014.
Critical roles of lncRNA-mediated autophagy in urologic malignancies.
Gan L, Zheng L, Zou J, Luo P, Chen T, Zou J
Front Pharmacol. 2024; 15:1405199.
PMID: 38939836
PMC: 11208713.
DOI: 10.3389/fphar.2024.1405199.
Cancer fusion transcripts with human non-coding RNAs.
Mohammad T, Zolotovskaia M, Suntsova M, Buzdin A
Front Oncol. 2024; 14:1415801.
PMID: 38919532
PMC: 11196610.
DOI: 10.3389/fonc.2024.1415801.
β-Elemene Reverses Gefitinib Resistance in NSCLC Cells by Inhibiting lncRNA H19-Mediated Autophagy.
Zhang R, Zheng Y, Zhu Q, Gu X, Xiang B, Gu X
Pharmaceuticals (Basel). 2024; 17(5).
PMID: 38794196
PMC: 11124058.
DOI: 10.3390/ph17050626.
NR1D1-transactivated lncRNA NUTM2A-AS1 promotes chemoresistance and immune evasion in neuroblastoma via inhibiting B7-H3 degradation.
Xiang T, Li Y, Liu G, Li X
J Cell Mol Med. 2024; 28(10):e18360.
PMID: 38785199
PMC: 11117458.
DOI: 10.1111/jcmm.18360.